Relationship Between the Clinical Pharmacist & Antibiotic Use by Using the Electronic Program

Alexandria University

Status: Completed

Conditions: Electronic Medical Record; Clinical Pharmacists

Treatments: Other: NO intervention

Study type: Observational

Funder types: Other

Identifiers

NCT05002647

14-2021/13

Details and patient eligibility

About

A retrospective cohort study to explore the association between clinical pharmacists' interventions and antibiotic consumption through the use of the medical electronic reports and to identify mortality and cost savings in hospital infectious disease.

Full description

The role of clinical pharmacist includes :

1. a check of suitable selection and dosing of antimicrobials according to the diagnosis, type of infection, antimicrobial cultures as possible, comorbidities of patients (renal or hepatic function, etc), adverse effect, and drug interaction with other drugs.
2. Documentation of the clinical intervention, cost-saving, adverse effect,, antimicrobial culture and antimicrobial consumption on the electronic program (CPC "clinical patient care").
3. The clinical pharmacist inspector reviews the data recorded on CPC.

Enrollment: 2,601 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All inpatient with infectious disease (disorders caused by organisms as (bacteria, viruses, fungi, or parasites).

Exclusion criteria

• Any other cause of hospital admission other than infectious disease.

Trial design

2,601 participants in 3 patient groups

exposure group

Description:

Data from electronic clinical pharmacist records of two infectious disease hospitals

Treatment:

Other: NO intervention

Non-exposure group A

Description:

Data from medical records of the hospital with no clinical pharmacy.

Treatment:

Other: NO intervention

Non-exposure group B

Description:

Data from a medical record of the hospital with clinical pharmacy, but the department did not cover by the clinical pharmacy

Treatment:

Other: NO intervention